Dr. John Jasper of Molecular Isotopes, LLC, and representatives from FDA and J&J will discuss the use of molecular isotopes to label, not pharmaceutical products, but the processes that are used to make them. They will make this presentation on February 21 at the IFPAC conference in Washington, D.C. (Watch for coverage of the conference on PharmaManufacturing and in Pharmaceutical Manufacuring magazine and PAT Insider).
For more information and PDFs of published papers, visit www.molecularisotopes.com
-AMS
